Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular level studies with anthracyclines.

E Eckle, E Kiefer, G Lauser

    Drugs Under Experimental and Clinical Research
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Colour duplex sonography of finger arteries in vasculitis and in systemic sclerosis.

    Annals of the rheumatic diseases·2006
    Same author

    Molecular recognition in cyclodextrin complexes of amino acid derivatives. 1. Crystallographic studies of beta-cyclodextrin complexes with N-acetyl-L-phenylalanine methyl ester and N-acetyl-L-phenylalanine amide pseudopeptides.

    Journal of the American Chemical Society·2001
    Same author

    Molecular recognition in cyclodextrin complexes of amino acid derivatives. 2. A new perturbation: the room-temperature crystallographic structure determination for the N-acetyl-p-methoxy-L-phenylalanine methyl ester/beta-cyclodextrin complex.

    Journal of the American Chemical Society·2001
    Same author

    Pseudopolymorphism in tetradeca-2,6-O-methyl-beta-cyclodextrin: the crystal structures for two new hydrates-conformational variability in the alkylated beta-cyclodextrin molecule.

    Journal of the American Chemical Society·2001
    Same author

    Preliminary X-ray diffraction studies of the transcriptional inhibitory antibody Fab41.4.

    Acta crystallographica. Section D, Biological crystallography·2001
    Same author

    Design and fabrication of a half-beam wedge for treatment of breast patients.

    Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2001

    Researchers are characterizing anthracyclines, a class of chemotherapeutic agents, at the molecular level. Studies involve X-ray crystallography and spectroscopy to understand their structure and interactions for improved drug design.

    Area of Science:

    • Molecular pharmacology and structural biology.
    • Medicinal chemistry and drug design.

    Background:

    • Growing interest in characterizing chemotherapeutic agents at the molecular level.
    • Understanding structural properties (configuration, conformation, tautomerism) and intermolecular interactions is crucial for designing new agents.
    • Anthracyclines, including daunomycin and nogalamycin families, are under investigation for their molecular behavior.

    Purpose of the Study:

    • To elucidate the molecular behavior of anthracyclines.
    • To understand the effect of chemical substitution on structural properties.
    • To gain insights into environmentally dependent intermolecular interactions.

    Main Methods:

    • Single crystal structure analysis using X-ray diffraction data.
    • Solution studies employing ultraviolet (UV) and circular dichroism (CD) spectroscopies.

    Related Experiment Videos

  • Determined crystal structures for specific anthracycline derivatives (7-con-O-methylnogarol, 7-deoxynogarol, 9-deacetyldaunomycin, AD-48, AD-32).
  • Main Results:

    • Elucidated crystal structures of several anthracycline derivatives.
    • Investigated the interaction of selected anthracyclines with specific oligonucleotide sequences (d-(5GTCATGAC), d-(5GTCGCGAC), d-(5GTCGTCA)/d-(5TGACGAC)).

    Conclusions:

    • Structural and solution studies provide molecular-level insights into anthracyclines.
    • These findings contribute to the understanding necessary for designing novel chemotherapeutic agents.
    • Further investigation into anthracycline-oligonucleotide interactions is warranted.